In the ever-evolving landscape of health care, artificial intelligence (AI) is emerging as a transformative force, bridging the gap between academic institutions and clinical practice. As reported by Oncology Nurse Advisor, AI is revolutionizing diagnostics, treatment, and patient care, with significant advancements particularly noted in fields like radiology and oncology.


AI’s potential to enhance diagnostic accuracy has been a focal point, as its integration with physician diagnoses is believed to improve confidence and system performance. The original article highlights how AI is being utilized to develop automated cancer detection software, which is crucial for early diagnosis and personalized treatment regimens.


AI in Academic vs Clinical Settings

While academic institutions are at the forefront of AI research, focusing on developing and validating digital therapeutic tools, clinical practices are leveraging AI primarily to improve workflow efficiency. Dr. Ravi B Parikh from the University of Pennsylvania emphasizes that AI tools approved by the FDA are often more accessible to larger academic health systems, leaving smaller clinics at a disadvantage due to cost and data limitations.


Despite these challenges, the potential for AI to reduce the administrative burden in clinical settings is promising. AI can streamline tasks such as billing and claims processing, which could significantly enhance patient satisfaction and management.


Remote Monitoring and Telemedicine

The COVID-19 pandemic has accelerated investment in remote monitoring technologies, with AI-powered wearables and virtual nursing assistants emerging as key tools for patient care. These innovations are particularly beneficial for underserved areas, where AI-driven diagnostic tools can aid health care professionals in making accurate diagnoses based on patient-reported symptoms.


However, device literacy remains a barrier, as noted by Dr. Parikh, who calls for solutions that enhance the ability to process patient visits and improve documentation without necessarily requiring FDA approval.


The Future of AI in Health Care

AI and machine learning hold the promise of more precise immune therapies, improved clinical decision-making, and ultimately, better patient outcomes. Dr. Parikh predicts that within the next 5 to 10 years, AI will become as integrated into health care as electronic health records once were.


As AI continues to evolve, the focus must remain on making these technologies accessible to all health care providers, ensuring that the benefits of AI are felt across both large academic systems and community-based health facilities.


More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

How Bluerate.ai Is Transforming the Mortgage Experience With AI

Bluerate.ai—formerly MyMortgageRates—is stepping into 2025 with a mission to modernize a mortgage process that has barely changed in decades. Built by Zeitro, the platform equips both borrowers and loan officers with powerful AI tools, from online pre‑qualification and automated financial data extraction to instant guideline answers and scenario analysis. With more than 3,000 verified NMLS‑licensed loan officers and real‑time rate comparisons from major lenders, Bluerate.ai is quickly becoming a must‑know platform for mortgage and real estate professionals seeking speed, clarity, and a fully digital lending experience.

Federal Housing Programs Restart After Shutdown — Here’s What Real Estate Pros Need to Know Now

After the longest government shutdown in U.S. history, key federal housing programs such as FHA, VA, USDA, and NFIP are officially back in operation—offering long‑awaited relief to agents, lenders, and insurance professionals. But with a six‑week backlog slowing everything from loan guarantees to flood-insurance renewals, real estate pros should brace for delays and focus on resetting client expectations. A new federal spending deal restores funding through early 2026 and gives the market room to breathe, while NAR’s aggressive advocacy helped push the government toward reopening. Now, professionals who communicate clearly and stay on top of regulatory updates will be best positioned to guide clients through the temporary turbulence.

The Digital Wave Transforming Commercial Real Estate

Commercial real estate is rapidly shifting toward a digital-first model, with platforms like Crexi leading the charge. By unifying property data, AI-driven insights, transparent bidding, and streamlined transaction tools, digital marketplaces are becoming essential to how modern CRE deals are sourced, analyzed, and closed. With more than 2 million monthly users and over $1 trillion in facilitated transactions, Crexi showcases how technology is reshaping the industry and giving real estate professionals a powerful competitive edge.

Europe’s Real Estate Giants Unite to Build a Game‑Changing Proptech Accelerator

Europe’s biggest landlords—including Aroundtown, Vonovia, and top global investors—have teamed up to launch ATechX, a powerful new accelerator giving proptech startups something they rarely get: access to real buildings, real customers, and a clear path to scale across multiple countries. Designed to move founders beyond “pilot purgatory,” ATechX offers a true sandbox for innovation in Europe’s aging, regulation‑heavy property market, helping promising technology reach commercial traction faster than ever.

Is Now the Moment to Buy? What Today’s Odd-but-Opportunistic Housing Market Really Means for You

Mortgage rates are finally easing, inventory is climbing, and buyers are gaining leverage for the first time in years — yet sky‑high prices and economic jitters are keeping many on pause. With economists warning that inflation could push rates higher again, this fall may offer a rare window for well‑prepared buyers. Here’s what’s driving the shift, where opportunities are emerging, and how real estate professionals can stay ahead.

Griffin Funding Brings on New SVP to Drive Bold $3B Non-QM Expansion

Griffin Funding has appointed John Jones as Senior Vice President of Growth and EOS Integrator, aiming to scale the company toward a $3 billion annual non-QM volume goal by 2030. After serving in fractional leadership roles since April 2025, Jones now steps in full‑time to lead organizational structure, efficiency, market expansion, and cross‑department alignment. Backed by strong liquidity and rising deal volume, Griffin Funding appears positioned for major industry impact in the years ahead.